VENTURE CAPITAL POST

President Joe Biden and Senator Bernie Sanders joined forces on Wednesday to promote lower health care costs, including inhalers.

The analyst at Keefe, Bruyette & Woods believed the breakup would increase shareholders value by 57%. However, Citigroup has asked its shareholders to vote against the too-big-to-fail proposal.

Bernie Sanders has cashed in on his small-dollar contributors and raised almost $5.1 million in a sudden, instant fundraiser on his victory night. Without a super-PAC to cushion his campaigns, he has always managed to keep pace with competition like Hilary Clinton, who's dependent on high-dollar contribution to fill her kitty. Sanders already knows exactly what he wants to do with the influx of cash.

Sen. Elizabeth Warren, D-Mass.presented a bill that would pay social security beneficiaries a one-time stipend intended to balance the absence of a cost living adjustment in 2016. Investment News reported that Warren's arrangement calls for the elimination of a tax reduction that allows companies to discount CEO rewards, authorizing the cash to pay those on Social Security.

The Justice Department launched an investigation on drug makers Merck & Co, Valeant Pharmaceuticals International, and Eli Lilly & Co for alleged over pricing. The Wall Street Journal reported that the US Attorney's office in Eastern District of Pennsylvania, along with the Justice Department's civil division set a probe on Merck, Eli Lilly, and Valeant on how these drug makers calculate and report their product pricing to the government medical rebate program.